Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.32 EUR
−22.66 M EUR
46.47 M EUR
35.41 M
About Apyx Medical Corporation
Sector
Industry
CEO
Charles D. Goodwin
Website
Headquarters
Clearwater
Founded
1978
IPO date
Jul 22, 1983
Identifiers
3
ISIN US03837C1062
Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used by the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacturer (OEM). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Apyx Medical Corporation stocks are traded under the ticker BOV.
We've gathered analysts' opinions on Apyx Medical Corporation future price: according to them, BOV price has a max estimate of 6.82 EUR and a min estimate of 4.27 EUR. Watch BOV chart and read a more detailed Apyx Medical Corporation stock forecast: see what analysts think of Apyx Medical Corporation and suggest that you do with its stocks.
Yes, you can track Apyx Medical Corporation financials in yearly and quarterly reports right on TradingView.
Apyx Medical Corporation is going to release the next earnings report on Mar 12, 2026. Keep track of upcoming events with our Earnings Calendar.
BOV earnings for the last quarter are −0.04 EUR per share, whereas the estimation was −0.09 EUR resulting in a 51.16% surprise. The estimated earnings for the next quarter are −0.05 EUR per share. See more details about Apyx Medical Corporation earnings.
Apyx Medical Corporation revenue for the last quarter amounts to 10.97 M EUR, despite the estimated figure of 10.23 M EUR. In the next quarter, revenue is expected to reach 15.43 M EUR.
BOV net income for the last quarter is −1.69 M EUR, while the quarter before that showed −3.21 M EUR of net income which accounts for 47.28% change. Track more Apyx Medical Corporation financial stats to get the full picture.
No, BOV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 15, 2026, the company has 220 employees. See our rating of the largest employees — is Apyx Medical Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Apyx Medical Corporation EBITDA is −7.61 M EUR, and current EBITDA margin is −37.93%. See more stats in Apyx Medical Corporation financial statements.
Like other stocks, BOV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Apyx Medical Corporation stock right from TradingView charts — choose your broker and connect to your account.